Chicago Pacific Founders UGP III, LLC - Sep 14, 2023 Form 4/A - Amendment Insider Report for P3 Health Partners Inc. (PIII)

Role
10%+ Owner
Signature
Chicago Pacific Founders UGP III, LLC, /s/ Michael J. Wilson, authorized signatory
Stock symbol
PIII
Transactions as of
Sep 14, 2023
Transactions value $
$227,142
Form type
4/A - Amendment
Date filed
9/10/2024, 05:56 PM
Date Of Original Report
Sep 15, 2023
Previous filing
Oct 4, 2023
Next filing
Sep 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PIII Class A Common Stock Purchase $227K +90K +0.18% $2.52 50.1M Sep 14, 2023 See Footnote F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On September 15, 2023, the reporting person filed a Form 4 which incorrectly stated that the purchase date in Column 2 of Table I was September 11, 2023 when the correct purchase date was September 14, 2023.
F2 Includes (i) 69,433.68 shares of Common Stock directly acquired by CPF III PT SPV, LLC ("SPV III") and (ii) 20,566.32 shares of Common Stock directly acquired by CPF III PT SPV-A, LLC ("SPV-A III").
F3 The price reported in Column 4 is a weighted-average price. These shares were purchased in multiple transactions at prices ranging from $2.45 to $2.70, inclusive. The reporting persons undertake to provide to P3 Health Partners Inc., any security holder of P3 Health Partners Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote 3.
F4 Chicago Pacific Founders UGP, III LLC ("UGP III") is the general partner of Chicago Founders GP III, LP ("GP III"), the general partner of each of SPV III and SPV III -A. As a result, UGP III has the power to vote and dispose of the Issuer's securities held by SPV III and SPV III -A (the "Underlying Securities"). Each of UGP III and GP III disclaims beneficial ownership for the amount in excess of their pecuniary interest in the Underlying Securities.